Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2189
Peer-review started: December 27, 2022
First decision: January 30, 2023
Revised: February 9, 2023
Accepted: March 10, 2023
Article in press: March 10, 2023
Published online: April 6, 2023
Processing time: 93 Days and 1.7 Hours
The coronavirus disease 2019 (COVID-19) initially presented as a disease that affected the lungs. Then, studies revealed that it intricately affected disparate organs in the human body, with the liver being one of the most affected organs. This review aimed to assess the association between COVID-19 and liver function, shedding light on its clinical implication. However, its exact pathophysiology remains unclear, involving many factors, such as active viral replication in the liver cells, direct cytotoxic effects of the virus on the liver or adverse reactions to viral antigens. Liver symptoms are mild-to-moderate transaminase elevation. In some patients, with underlying liver disease, more serious outcomes are observed. Thus, liver function should be meticulously considered in patients with COVID-19.
Core Tip: Coronavirus disease or coronavirus disease 2019 (COVID-19) is not only a respiratory illness but it can also affect the gastrointestinal system particularly the liver. Although the exact pathophysiology is unknown, more serious outcomes are seen when there is an underlying liver disease. Meticulous attention should be given to liver function in patients with COVID-19 infection.
